National Peroxide Limited (BOM:544205)
India · Delayed Price · Currency is INR 602.80
+14.80 (2.52%)
At close: Oct 1, 2026
National Peroxide Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
| 3,191 | 2,897 | 2,869 | 3,330 | |
Revenue Growth | 14.16% | 0.99% | -13.85% | - |
Cost of Revenue | 2,045 | 1,978 | 2,075 | 2,227 |
Gross Profit | 1,147 | 918.73 | 793.78 | 1,103 |
Selling, General & Admin | 269.73 | 265.18 | 304.41 | 292.75 |
Other Operating Expenses | 490.84 | 411.15 | 337.27 | 434.45 |
Operating Expenses | 969.9 | 884.23 | 842.76 | 919.8 |
Operating Income | 176.72 | 34.5 | -48.98 | 183.32 |
Interest Expense | -12.56 | -13.55 | -16.65 | -19.82 |
Interest & Investment Income | - | 10.27 | 6.64 | 5.14 |
Currency Exchange Gain (Loss) | - | 26.96 | 4.05 | 6.03 |
Other Non Operating Income (Expenses) | 60.72 | 3.55 | 9.92 | 12.9 |
EBT Excluding Unusual Items | 224.88 | 61.74 | -45.03 | 187.57 |
Gain (Loss) on Sale of Investments | - | 18.94 | 24.26 | 25.43 |
Gain (Loss) on Sale of Assets | - | - | - | 2.13 |
Other Unusual Items | -5.82 | -5.82 | - | - |
Pretax Income | 219.06 | 74.86 | -20.77 | 215.14 |
Income Tax Expense | 51.5 | 16.61 | 1.7 | 47.24 |
Net Income | 167.56 | 58.24 | -22.46 | 167.9 |
Net Income to Common | 167.56 | 58.24 | -22.46 | 167.9 |
Net Income Growth | - | - | - | - |
Shares Outstanding (Basic) | 6 | 6 | 6 | 6 |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 |
Shares Change | 0.07% | - | - | - |
EPS (Basic) | 29.14 | 10.13 | -3.91 | 29.22 |
EPS (Diluted) | 29.14 | 10.13 | -3.91 | 29.22 |
EPS Growth | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 |
Free Cash Flow | - | 297.91 | 137.78 | 217.7 |
Free Cash Flow Per Share | - | 51.84 | 23.97 | 37.88 |
Dividend Per Share | - | 7.000 | - | 12.500 |
Dividend Growth | - | - | - | - |
Gross Margin | 35.93% | 31.71% | 27.67% | 33.13% |
Operating Margin | 5.54% | 1.19% | -1.71% | 5.50% |
Profit Margin | 5.25% | 2.01% | -0.78% | 5.04% |
Free Cash Flow Margin | - | 10.28% | 4.80% | 6.54% |
EBITDA | 388.04 | 233.92 | 145.24 | 367.33 |
EBITDA Margin | 12.16% | 8.07% | 5.06% | 11.03% |
D&A For EBITDA | 211.32 | 199.42 | 194.22 | 184.01 |
EBIT | 176.72 | 34.5 | -48.98 | 183.32 |
EBIT Margin | 5.54% | 1.19% | -1.71% | 5.50% |
Effective Tax Rate | 23.51% | 22.20% | - | 21.96% |
Revenue as Reported | 3,252 | 2,957 | 2,914 | 3,381 |